Ruth E. Langley
MRC Clinical Trials Unit at UCL(GB)University College London(GB)Medical Research Council(GB)
Publications by Year
Research Areas
Gastric Cancer Management and Outcomes, Prostate Cancer Treatment and Research, Esophageal Cancer Research and Treatment, Lung Cancer Treatments and Mutations, Inflammatory mediators and NSAID effects
Most-Cited Works
- → Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer(2006)6,297 cited
- → Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial(2018)1,235 cited
- → Long-Term Results of a Randomized Trial of Surgery With or Without Preoperative Chemotherapy in Esophageal Cancer(2009)985 cited
- → Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial(2016)713 cited
- → Mismatch Repair Deficiency, Microsatellite Instability, and Survival(2017)514 cited
- → Individual Patient Data Meta-Analysis of the Value of Microsatellite Instability As a Biomarker in Gastric Cancer